(Q33183125)

23 July 2017

1 reference

title

Role of ACE inhibitors in patients with diabetes mellitus (English)

1 reference

23 July 2017

Cordonnier DJ

1

1 reference

23 July 2017

Zaoui P

series ordinal

2

1 reference

23 July 2017

Halimi S

series ordinal

3

1 reference

23 July 2017

1 January 2001

1 reference

23 July 2017

1 reference

23 July 2017

61

1 reference

23 July 2017

13

1 reference

23 July 2017

1883-1892

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161130-00001

23 July 2017

0 references

cites work

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

The HOPE study and diabetes. Heart Outcomes Prevention Evaluation

1 reference

12 December 2020

Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients

1 reference

12 December 2020

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy

1 reference

12 December 2020

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

The management of chronic heart failure

1 reference

12 December 2020

The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

1 reference

12 December 2020

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

12 December 2020

The HOPE study and diabetes

1 reference

12 December 2020

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

12 December 2020

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

12 December 2020

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

12 December 2020

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

1 reference

12 December 2020

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction

1 reference

12 December 2020

Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy

1 reference

12 December 2020

Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease

1 reference

12 December 2020

Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?

1 reference

12 December 2020

Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril

1 reference

12 December 2020

Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

12 December 2020

Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan

1 reference

12 December 2020

Serum angiotensin converting enzyme in diabetic patients

1 reference

12 December 2020

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

12 December 2020

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

12 December 2020

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

1 reference

12 December 2020

The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction.

1 reference

12 December 2020

Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes

1 reference

12 December 2020

Raised arterial pressure in parents of proteinuric insulin dependent diabetics.

1 reference

12 December 2020

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

1 reference

12 December 2020

Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure

1 reference

12 December 2020

Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach

1 reference

12 December 2020

An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

1 reference

12 December 2020

Hypertension as a risk factor for diabetic neuropathy: a prospective study

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats

1 reference

12 December 2020

The pathology of human diabetic neuropathy

1 reference

12 December 2020

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

12 December 2020

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Angiotensin levels in the eye

1 reference

12 December 2020

Clinical correlates of advanced retinopathy in type II diabetic patients: implications for screening. The CODIAB-INSERM-Zeneca Pharma Study Group

1 reference

12 December 2020

The Heart Outcomes Protection Evaluation (HOPE) study: relevance to ophthalmological practice?

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients

1 reference

12 December 2020

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Angiotensin II, VEGF, and diabetic retinopathy

1 reference

12 December 2020

Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients

1 reference

12 December 2020

Glomerular involvement in type II diabetes - is it all diabetic glomerulosclerosis?

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy

1 reference

12 December 2020

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

1 reference

12 December 2020

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

12 December 2020

High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy.

1 reference

12 December 2020

Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group

1 reference

12 December 2020

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy

1 reference

12 December 2020

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

12 December 2020

10.2165/00003495-200161130-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference